Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder

• DOI: 10.1007/s00737-016-0631-7
• Publication Date: 2016-07-05T02:08:53Z
• Authors: Elgerta Ismaili; Sally Walsh; Patrick Michael S...; Torbjorn Bäckström; Candace Brown; Lorraine Dennerstein; Elias Eriksson; Ellen W. Freeman; Khaled M. K. Ismail; Nicholas Panay; Teri Pearlstein; Andrea Rapkin; Meir Steiner; John Studd; Inger Sundström-P...; Jean Endicott; C. Neill Epperson; Uriel Halbreich; Robert Reid; David Rubinow; Peter Schmidt; Kimberley Yonkers
• Keywords: Consensus; Commission on Professional and Hospital Activities; International Cooperation; Standard of Care; Reference Standards; Patient Care Management; 3. Good health; Premenstrual Syndrome; 03 medical and health sciences; 0302 clinical medicine; Humans; Female; Premenstrual Dysphoric Disorder

Whilst professional bodies such as the Royal College and the American College of Obstetricians and Gynecologists have well-established standards for audit of management for most gynaecology disorders, such standards for premenstrual disorders (PMDs) have yet to be developed. The International Society of Premenstrual Disorders (ISPMD) has already published three consensus papers on PMDs covering areas that include definition, classification/quantification, clinical trial design and management (American College Obstetricians and Gynecologists 2011; Brown et al. in Cochrane Database Syst Rev 2:CD001396, 2009; Dickerson et al. in Am Fam Physician 67(8):1743-1752, 2003). In this fourth consensus of ISPMD, we aim to create a set of auditable standards for the clinical management of PMDs. All members of the original ISPMD consensus group were invited to submit one or more auditable standards to be eligible in the inclusion of the consensus. Ninety-five percent of members (18/19) responded with at least one auditable standard. A total of 66 auditable standards were received, which were returned to all group members who then ranked the standards in order of priority, before the results were collated. Proposed standards related to the diagnosis of PMDs identified the importance of obtaining an accurate history, that a symptom diary should be kept for 2 months prior to diagnosis and that symptom reporting demonstrates symptoms in the premenstrual phase of the menstrual cycle and relieved by menstruation. Regarding treatment, the most important standards were the use of selective serotonin reuptake inhibitors (SSRIs) as a first line treatment, an evidence-based approach to treatment and that SSRI side effects are properly explained to patients. A set of comprehensive standards to be used in the diagnosis and treatment of PMD has been established, for which PMD management can be audited against for standardised and improved care.